The CureVac vaccine, supported by Tesla Motor and SpaceX founder Elon Musk, was not effective against coronavirus. The effectiveness of the mRNA-based vaccine against coronavirus was 47 percent! As soon as the announced report was made, the shares lost nearly 50 percent of its value.
CureVac shares closed at $95 yesterday. However, as soon as it closed, it decreased to $ 43 in the transactions that took place.
The event results of the Germany-based company CureVac have emerged. The vaccine, which is mRNA-based, turned out to be 47 percent effective against the coronavirus, the results of which were announced after the trials in which 40 thousand volunteers participated.
However, the CEO of the company is still hopeful… CEOFranz-Werner Haas said that they will complete the trials and said, “There is a great need for a vaccine. We think we can contribute in some way.”
Source: Haber Global